“…Compared with earlier methods such as activation likelihood estimation and multilevel kernel density analysis ( 41 , 42 ), the AES‐SDM has strengths as below: (a) In the AES-SDM, both positive and negative differences in the same map are combined to avoid a particular voxel from appearing to be significant in opposite directions ( 43 ); (b) The AES-SDM approach allows reported peak coordinates to be combined with statistical parametric maps, thus ensuring more exhaustive and accurate meta‐analyses ( 44 ); (c) SDM enables several complementary analyses, such as jack-knife, subgroup, and meta-regression analyses, which can be used to evaluate the robustness and heterogeneity of the results ( 40 ). The AES-SDM method has been fully validated in several neuropsychiatric disorders including Parkinson’s disease ( 45 , 46 ), major depressive disorder (MDD) ( 29 ), bipolar disorder ( 47 ), obsessive‐compulsive disorder ( 43 , 48 , 49 ), autism spectrum disorder ( 50 ), type 1 diabetes mellitus (T1DM) ( 51 ), and also in voxel-based morphometry (VBM) studies in T2DM patients ( 52 , 53 ).…”